Back to search

Article

Medicare Payment for Calcium Modification Technologies Among Patients Undergoing Percutaneous Coronary Intervention, 2021-2022

2025-01-13

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The Centers for Medicare and Medicaid Services (CMS) New Technology Add-on Payment (NTAP) program supports adoption of new, costly medical technologies demonstrating substantial clinical improvement. In 2021, CMS waived the “substantial clinical improvement” criterion for devices designated under the FDA Breakthrough Devices Program (BDP). This study characterized risk-standar...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8073849-694f-5765-9f2f-6971e4a27ee4
DOI
10.1101/2025.01.12.25320423
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Medicare Payment for Calcium Modification Technologies Among Patients Undergoing Percutaneous Coronary Intervention, 2021-2022DOI 10.1101/2025.01.12.25320423
Select a neighboring publication to make it the new centre.